Procter & Gamble Company (The) (NYSE:PG – Get Free Report) CFO Andre Schulten sold 3,914 shares of the stock in a transaction on Monday, October 5th. The stock was sold at an average price of $145.34, for a total transaction of $568,860.76. Following the sale, the chief financial officer directly owned 65,618 shares in the company, valued at $9,536,920.12. This trade represents a 5.63% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The sale was made to cover tax withholding obligations related to the vesting of equity awards.
Procter & Gamble Stock Up 1.9%
PG opened at $150.60 on Friday. The company has a fifty day moving average of $145.82 and a two-hundred day moving average of $146.04. The stock has a market capitalization of $349.79 billion, a price-to-earnings ratio of 22.75, a PEG ratio of 3.67 and a beta of 0.39. Procter & Gamble Company has a fifty-two week low of $137.62 and a fifty-two week high of $167.25. The company has a debt-to-equity ratio of 0.43, a quick ratio of 0.47 and a current ratio of 0.68.
Procter & Gamble (NYSE:PG – Get Free Report) last posted its earnings results on Wednesday, July 29th. The company reported $1.43 EPS for the quarter, beating analysts’ consensus estimates of $1.41 by $0.02. Procter & Gamble had a return on equity of 31.36% and a net margin of 18.44%.The firm had revenue of $21.20 billion for the quarter, compared to analysts’ expectations of $21.38 billion. The company’s quarterly revenue was up 1.5% on a year-over-year basis. During the same period last year, the firm earned $1.48 EPS. Procter & Gamble has set its FY 2027 guidance at 6.890-7.110 EPS. On average, research analysts expect that Procter & Gamble Company will post 6.98 earnings per share for the current year.
Procter & Gamble Announces Dividend
Analyst Upgrades and Downgrades
Several equities research analysts recently commented on PG shares. Evercore raised shares of Procter & Gamble from an “in-line” rating to an “outperform” rating and set a $166.00 price target for the company in a report on Tuesday. JPMorgan Chase & Co. dropped their target price on shares of Procter & Gamble from $164.00 to $162.00 and set an “overweight” rating on the stock in a research report on Thursday, July 16th. Sanford C. Bernstein reissued a “market perform” rating and set a $149.00 target price on shares of Procter & Gamble in a research note on Monday, August 24th. BMO Capital Markets upped their price target on shares of Procter & Gamble from $169.00 to $170.00 and gave the stock an “outperform” rating in a research report on Monday, June 29th. Finally, Argus lowered shares of Procter & Gamble from a “buy” rating to a “hold” rating in a research note on Friday, August 7th. Fourteen analysts have rated the stock with a Buy rating and ten have issued a Hold rating to the company’s stock. According to data from MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average price target of $161.70.
Check Out Our Latest Stock Report on Procter & Gamble
Key Headlines Impacting Procter & Gamble
Here are the key news stories impacting Procter & Gamble this week:
- Positive Sentiment: Analyst upgrade supports the shares: Evercore ISI upgraded PG to “outperform” and set a $166 price target, citing potential for the stock to perform better through the remainder of 2026. The broader analyst consensus remains “Moderate Buy,” with an average target of $161.70. Analyst upgrade article
- Positive Sentiment: Dividend and defensive characteristics remain attractive: P&G has increased its dividend for 70 consecutive years. Its approximately 2.9% yield and stable portfolio of household brands may appeal to income-focused investors, particularly during periods of market uncertainty. Dividend stocks article
- Positive Sentiment: Management continues to identify avenues for growth: Despite only 1.5% year-over-year revenue growth in the latest quarter, management has outlined a specific opportunity to expand sales, giving investors a potential catalyst beyond P&G’s mature core categories. P&G growth opportunity article
- Neutral Sentiment: Upcoming investor events may provide additional direction: P&G’s October 13 virtual annual meeting and upcoming earnings report are in focus. Investors will be watching for updates on growth, fiscal 2027 guidance and capital allocation. Annual meeting and earnings article
- Neutral Sentiment: Brand and marketing initiatives continue: P&G announced a McLaren Formula 1 partnership in Asia Pacific and launched Pantene’s Cream to Mist leave-in treatment. These efforts could support consumer engagement, but their near-term financial impact is unclear. P&G McLaren partnership article
- Negative Sentiment: Near-term growth remains a concern: Analysts expect upcoming quarterly earnings to decline on a year-over-year basis. P&G’s latest revenue also trailed estimates, reinforcing concerns about limited volume growth and a premium valuation.
- Neutral Sentiment: Insider sales appear administrative: CEO Paul Gama and director Susan Street Whaley sold shares, with the CEO’s transaction attributed to tax withholding on vested equity awards. The sales are therefore a limited bearish signal. P&G insider sales article
Hedge Funds Weigh In On Procter & Gamble
A number of institutional investors and hedge funds have recently added to or reduced their stakes in PG. Baxter Bros Inc. purchased a new stake in Procter & Gamble during the 2nd quarter worth approximately $12,381,000. Empowered Funds LLC purchased a new position in Procter & Gamble in the 2nd quarter valued at approximately $53,549,000. Resources Management Corp CT ADV grew its stake in shares of Procter & Gamble by 41.8% in the fourth quarter. Resources Management Corp CT ADV now owns 81,511 shares of the company’s stock worth $11,681,000 after acquiring an additional 24,010 shares in the last quarter. Bank of America Corp DE purchased a new stake in shares of Procter & Gamble during the second quarter worth $3,850,628,000. Finally, Rokos Capital Management LLP purchased a new stake in shares of Procter & Gamble during the first quarter worth $29,914,000. Institutional investors and hedge funds own 65.77% of the company’s stock.
Procter & Gamble Company Profile
The Procter & Gamble Company (NYSE: PG) is a consumer products company that develops, manufactures and markets branded products used in households and personal care routines. Its portfolio includes products in categories such as beauty, grooming, health care, fabric and home care, and family care.
Major brands associated with Procter & Gamble include Pampers, Tide, Gillette, Head & Shoulders, Pantene, Oral-B, Crest, Olay, Old Spice, Febreze, Mr. Clean, Swiffer and Bounty. The company sells its products through retailers, e-commerce platforms and other distribution channels.
Founded in Cincinnati, Ohio, in 1837 by William Procter and James Gamble, the company has grown into a global consumer goods business serving customers in markets around the world.
Recommended Stories
- Five stocks we like better than Procter & Gamble
- Want Private-Market Access to Kalshi and Polymarket? Try This ETF
- Levi’s Stock Dip Reveals Value Opportunity Despite Q3 Headwinds
- PepsiCo Stock Looks Poised to Bottom With High Yield, Deep Value
- Alphabet’s $1.8 Billion Black Hills Deal Powers AI Data Center Push
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.
